Renal phenotype is exacerbated in Os and lpr double mutant mice

Kidney International

Volumn 66, Issue 3, 2004, Pages 1029-1035

  Jarad, George ^b   Lakhe Reddy, Sujata ^b   Blatnik, Jeffrey ^b   Koepke, Morgan ^b   Khan, Shenaz ^b   El Meanawy, M Ashraf ^b   O'Connor, Andrew S ^b   Sedor, John A ^b   Schelling, Jeffrey R ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

^b NONE

Author keywords

Albuminuria; Glomerulosclerosis; Mouse models; Proteinuria; Renal disease progression

Indexed keywords

CREATININE; FAS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS BREEDING; DISEASE EXACERBATION; FEMALE; GENE INTERACTION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; GLOMERULOSCLEROSIS; GLOMERULUS EPITHELIUM; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY INTERSTITIUM; KIDNEY MASS; KIDNEY TUBULE CELL; MALE; MOUSE; MULTIVARIATE ANALYSIS; NEPHRITIS; NONHUMAN; OLIGOSYNDACTYLISM; PHENOTYPE; PRIORITY JOURNAL; PROTEINURIA; SYNDACTYLY;

EID: 4344589589     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00851.x     Document Type: Article

References (30)

1. EL-MEANAWY MA, SCHELLING JR, POZUELO F, et al: Use of serial analysis of gene expression to generate kidney expression libraries. Am J Physiol 279:F383-F392, 2000
2. LENZ O, TEICHMANN U, LANGERS A, et al. Linkage disequilibrium mapping reveals suppressed recombination at the Os locus. Mamm Genome 9:681-682, 1998
3. PRAVTCHEVA DD, WISE TL: Disruption of Apc10/Doc1 in three alleles of oligosyndactylism. Genomics 72:78-87, 2001
4. MAGNUSON T, EPSTEIN CJ: Oligosyndactyly: A lethal mutation in the mouse that results in mitotic arrest very early in development. Cell 38:823-833, 1984
5. ZALUPS RK: The Os/+ mouse: A genetic animal model of reduced renal mass. Am J Physiol 264:F53-F60, 1993
6. HE C, ZALUPS RK, HENDERSON DA, et al: Molecular analysis of spontaneous glomerulosclerosis in Os/+ mice, a model with reduced nephron mass. Am J Physiol 269:F266-F273, 1995
7. HE CJ, ESPOSITO C, PHILLIPS C, et al: Dissociation of glomerular hypertrophy, cell proliferation, and glomerulosclerosis in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number. J Clin Invest 97:1242-1249, 1996
8. SCHELLING JR, EL-MEANAWY MA, BARATHAN S, et al: Generation of kidney transcriptomes using serial analysis of gene expression. Exp Nephrol 10:82-92, 2002
9. SCHELLING JR, NKEMERE N, KOPP JB, CLEVELAND RP: Fas-dependent fratricidal apoptosis is a mechanism of tubular epithelial cell deletion in chronic renal failure. Lab Invest 78:813-824, 1998
10. KHAN S, CLEVELAND RP, KOCH CJ, SCHELLING JR: Hypoxia induces renal tubular epithelial cell apoptosis in chronic renal disease. Lab Invest 79:1089-1099, 1999
11. ORTIZ-ARDUAN A, DANOFF TM, KALLURI R, et al: Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia. Am J Physiol 271:F1193-F1201, 1996
12. KHAN S, KOEPKE A, JARAD G, et al: Apoptosis and JNK activation are differentially regulated by Fas expression level in renal tubular epithelial cells. Kidney Int 60:65-76, 2001
13. NOGAE S, MIYAZAKI M, KOBAYASHI N, et al: Induction of apoptosis in ischemia-reperfusion model of mouse kidney: Possible involvement of Fas. J Am Soc Nephrol 9:620-631, 1998
14. HUGHES J, JOHNSON RJ: Role of Fas (CD95) in tubulointerstitial disease induced by unilateral ureteric obstruction. Am J Physiol 277:F26-F32, 1999
15. WATANABE-FUKANAGA R, BRANNAN CI, COPELAND NG, et al: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317, 1992
16. ADACHI M, WATANABE-FUKANAGA R, NAGATA S: Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci USA 90:1756-1760, 1993
17. KELLEY VE, ROTHS JB: Interaction of mutant lpr gene with background strain influences renal disease. Clin Immunol Immunopathol 37:220-229, 1985
18. KIMURA M, TAKAHASI H, OHTAKE T, et al: Interstrain differences in murine daunomycin-induced nephrosis. Nephron 63:193-198, 1993
19. KABRA NH, CADO D, WINOTO A: A tailless Fas-FADD death-effector domain chimera is sufficient to execute Fas function in T cells but not B cells of MRL-lpr/lpr mice. J Immunol 162:2766-2774, 1999
20. MACKAY K, STRIKER LJ, STAUFFER JW, et al: Relationship of glomerular hypertrophy and sclerosis: Studies in SV40 transgenic mice. Kidney Int 37:741-748, 1990
21. SCHELLING JR, GENTRY DJ, DUBYAK GR: Annexin II inhibition of G protein-regulated inositol trisphosphate formation in rat aortic smooth muscle. Am J Physiol 270:F682-F690, 1996
22. MENETON P, ICHIKAWA I, INAGAMI T, et al: Renal physiology of the mouse. Am J Physiol Renal Physiol 278:F339-F351, 2000
23. SAVILL J: Apoptosis and the kidney. J Am Soc Nephrol 5:12-21, 1994
24. DESBARATS J, NEWELL MK: Fas engagement accelerates liver regeneration after partial hepatectomy. Nat Med 6:920-923, 2000
25. ROTHMAN KJ: Measuring interactions, in Epidemiology. An Introduction, Oxford, Oxford University Press, 2002, pp 168-180
26. LENZ O, ZHENG F, VILAR J, et al: The inheritance of glomerulosclerosis in mice is controlled by multiple quantitative trait loci. Nephrol Dial Transplant 13:3074-3078, 1998
27. ELLIOT SJ, KARL M, BERHO M, et al: Estrogen deficiency accelerates progression of glomerulosclerosis in susceptible mice. Am J Pathol 162:1441-1448, 2003
28. PILLEBOUT E, WEITZMAN JB, BURTIN M, et al: JunD protects against chronic kidney disease by regulating paracrine mitogens. J Clin Invest 112:843-852, 2003
29. ZHENG F, STRIKER GE, ESPOSITO C, et al: Strain differences/rather than hyperglycemia determine the severity of glomerulosclerosis in mice. Kidney Int 54:1999-2007, 1998
30. ESPOSITO C, HE CJ, STRIKER GE, et al: Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice. Am J Pathol 154:891-897, 1999